Literature DB >> 19589493

Diagnostic ability of Fourier-domain vs time-domain optical coherence tomography for glaucoma detection.

Mitra Sehi1, Dilraj S Grewal, Clinton W Sheets, David S Greenfield.   

Abstract

PURPOSE: To compare retinal nerve fiber layer (RNFL) thickness assessments and the discriminating ability of Fourier-domain optical coherence tomography (FD-OCT) with that of time-domain optical coherence tomography (TD-OCT) for glaucoma detection.
DESIGN: Prospective, nonrandomized, observational cohort study.
METHODS: Normal and glaucomatous eyes underwent complete examination, standard automated perimetry, optic disc photography, TD-OCT (Stratus OCT; Carl Zeiss Meditec, Dublin, California, USA), and FD-OCT (RTVue; Optovue Inc, Fremont, California, USA). One eye per subject was enrolled. Two consecutive scans were acquired using a 3.46-mm diameter scan with TD-OCT and a 3.45-mm diameter scan with FD-OCT. For each of 5 RNFL parameters, the area under the receiver operator characteristic curve was calculated to compare the ability of FD-OCT and TD-OCT to discriminate between normal and glaucomatous eyes.
RESULTS: Fifty healthy persons (mean age, 65.3 +/- 9.9 years) and 50 glaucoma patients (mean age, 67.7 +/- 10.5 years) were enrolled. Average, superior, and inferior RNFL thickness measurements (in micrometers) were significantly (P < .01) greater with FD-OCT compared with TD-OCT in normal eyes (103.3 +/- 12.6 vs 96.3 +/- 10.7, 134.5 +/- 18.6 vs 113.9 +/- 16.3, and 129.7 +/- 16.9 vs 125.5 +/- 15.8, respectively) and glaucomatous eyes (P < .001; 77.6 +/- 17.6 vs 70.4 +/- 18.6, 108.0 +/- 26.8 vs 86.8 +/- 30.2, 82.2 +/- 3.3 vs 73.5 +/- 26.1, respectively). The area under the receiver operator characteristic curves for RNFL thickness were similar (P > .05) using FD-OCT (average, 0.88; superior, 0.80; inferior, 0.94) and TD-OCT (average, 0.87; superior, 0.79; inferior, 0.95).
CONCLUSIONS: Cross-sectional peripapillary RNFL thickness measurements obtained using FD-OCT generated with the RTVue are greater than those obtained with TD-OCT and have similar diagnostic performance for glaucoma detection.

Entities:  

Mesh:

Year:  2009        PMID: 19589493      PMCID: PMC2784699          DOI: 10.1016/j.ajo.2009.05.030

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  33 in total

Review 1.  Recent developments in optical coherence tomography for imaging the retina.

Authors:  Mirjam E J van Velthoven; Dirk J Faber; Frank D Verbraak; Ton G van Leeuwen; Marc D de Smet
Journal:  Prog Retin Eye Res       Date:  2006-12-08       Impact factor: 21.198

Review 2.  Role of optic nerve imaging in glaucoma clinical practice and clinical trials.

Authors:  David S Greenfield; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2008-03-04       Impact factor: 5.258

3.  Optic disc imaging in perimetrically normal eyes of glaucoma patients with unilateral field loss.

Authors:  Joseph Caprioli; Kouros Nouri-Mahdavi; Simon K Law; Federico Badalà
Journal:  Trans Am Ophthalmol Soc       Date:  2006

4.  Scanning laser polarimetry with enhanced corneal compensation and optical coherence tomography in normal and glaucomatous eyes.

Authors:  Mitra Sehi; Stephen Ume; David S Greenfield
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-05       Impact factor: 4.799

5.  Sources of longitudinal variability in optical coherence tomography nerve-fibre layer measurements.

Authors:  L Kagemann; T Mumcuoglu; G Wollstein; R Bilonick; H Ishikawa; K A Townsend; M Gabriele; J G Fujimoto; J S Schuman
Journal:  Br J Ophthalmol       Date:  2008-06       Impact factor: 4.638

6.  Discrimination between glaucomatous and nonglaucomatous eyes using quantitative imaging devices and subjective optic nerve head assessment.

Authors:  Julio E Deleón-Ortega; Stella N Arthur; Gerald McGwin; Aiyuan Xie; Blythe E Monheit; Christopher A Girkin
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

7.  Determinants of normal retinal nerve fiber layer thickness measured by Stratus OCT.

Authors:  Donald L Budenz; Douglas R Anderson; Rohit Varma; Joel Schuman; Louis Cantor; Jonathan Savell; David S Greenfield; Vincent Michael Patella; Harry A Quigley; James Tielsch
Journal:  Ophthalmology       Date:  2007-01-08       Impact factor: 12.079

8.  Factors associated with variability in retinal nerve fiber layer thickness measurements obtained by optical coherence tomography.

Authors:  Ziqiang Wu; Matti Vazeen; Rohit Varma; Vikas Chopra; Alexander C Walsh; Laurie D LaBree; Srinivas R Sadda
Journal:  Ophthalmology       Date:  2007-03-23       Impact factor: 12.079

9.  A pilot study of Fourier-domain optical coherence tomography of retinal dystrophy patients.

Authors:  Jennifer I Lim; Ou Tan; Amani A Fawzi; J Jill Hopkins; John H Gil-Flamer; David Huang
Journal:  Am J Ophthalmol       Date:  2008-07-17       Impact factor: 5.258

10.  Optic nerve head and retinal nerve fiber layer analysis: a report by the American Academy of Ophthalmology.

Authors:  Shan C Lin; Kuldev Singh; Henry D Jampel; Elizabeth A Hodapp; Scott D Smith; Brian A Francis; David K Dueker; Robert D Fechtner; John S Samples; Joel S Schuman; Don S Minckler
Journal:  Ophthalmology       Date:  2007-10       Impact factor: 12.079

View more
  44 in total

1.  Glaucoma research community and FDA look to the future, II: NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: measures of structural change and visual function.

Authors:  Robert N Weinreb; Paul L Kaufman
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-04       Impact factor: 4.799

Review 2.  Imaging of the retinal nerve fibre layer with spectral domain optical coherence tomography for glaucoma diagnosis.

Authors:  Kyung Rim Sung; Jong S Kim; Gadi Wollstein; Lindsey Folio; Michael S Kook; Joel S Schuman
Journal:  Br J Ophthalmol       Date:  2010-10-28       Impact factor: 4.638

3.  The comparison of manual vs automated disc margin delineation using spectral-domain optical coherence tomography.

Authors:  S M Iverson; M Sehi
Journal:  Eye (Lond)       Date:  2013-08-02       Impact factor: 3.775

4.  Diagnostic performance and reproducibility of circumpapillary retinal nerve fiber layer thickness measurement in 10-degree sectors in early stage glaucoma.

Authors:  Hiroyo Hirasawa; Chihiro Mayama; Atsuo Tomidokoro; Makoto Araie; Aiko Iwase; Kazuhisa Sugiyama; Shoji Kishi; Naoyuki Maeda; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2014-12-19       Impact factor: 2.447

5.  [Principles of glaucoma diagnostics with optical coherence tomography].

Authors:  C Y Mardin
Journal:  Ophthalmologe       Date:  2015-08       Impact factor: 1.059

6.  Diagnostic capability of peripapillary retinal nerve fiber layer parameters in time-domain versus spectral-domain optical coherence tomography for assessing glaucoma in high myopia.

Authors:  Mei-Ching Teng; Yi-Chieh Poon; Kuo-Chi Hung; Hsueh-Wen Chang; Ing-Chou Lai; Jen-Chia Tsai; Pei-Wen Lin; Chien-Yun Wu; Chueh-Tan Chen; Pei-Chang Wu
Journal:  Int J Ophthalmol       Date:  2017-07-18       Impact factor: 1.779

7.  Comparison of two different spectral domain optical coherence tomography devices in the detection of localized retinal nerve fiber layer defects.

Authors:  Ko Eun Kim; Seong Joon Ahn; Dong Myung Kim
Journal:  Jpn J Ophthalmol       Date:  2013-03-29       Impact factor: 2.447

8.  Diagnostic capability of spectral-domain optical coherence tomography for glaucoma.

Authors:  Huijuan Wu; Johannes F de Boer; Teresa C Chen
Journal:  Am J Ophthalmol       Date:  2012-01-20       Impact factor: 5.258

9.  Evaluation of baseline structural factors for predicting glaucomatous visual-field progression using optical coherence tomography, scanning laser polarimetry and confocal scanning laser ophthalmoscopy.

Authors:  M Sehi; N Bhardwaj; Y S Chung; D S Greenfield
Journal:  Eye (Lond)       Date:  2012-10-12       Impact factor: 3.775

10.  Diagnosing preperimetric glaucoma with spectral domain optical coherence tomography.

Authors:  Renato Lisboa; Mauro T Leite; Linda M Zangwill; Ali Tafreshi; Robert N Weinreb; Felipe A Medeiros
Journal:  Ophthalmology       Date:  2012-08-09       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.